3 Year MiSight Contact Lens Trial Results

The results of the 3 year MiSight contact lens trial for myopia is finally published. Dr Cheryl Ngo has been involved in this study for 6 years in studying the effects of slowing down myopia in children. Read the abstract from the study here!

A 3-Year Randomized Clinical Trial of MiSight Lenses for Myopia Control

Chamberlain, Paul BSc; Peixoto-de-Matos, Sofia C. MSc; Logan, Nicola S. PhD; Ngo, Cheryl MBBS, MMed; Jones, Deborah BSc, FAAO; Young, Graeme PhD, FAAO

Optometry and Vision Science: July 19, 2019 – Volume Pre-Publication – Issue – p
doi: 10.1097/OPX.0000000000001410
CLINICAL TRIAL: PDF Only

SIGNIFICANCE Results of this randomized, double-masked clinical trial demonstrate the effectiveness of the MiSight soft contact lens in slowing myopia progression over multiple years.

PURPOSE The purpose of this study was to quantify the effectiveness of MiSight daily disposable soft contact lens in slowing the progression of juvenile-onset myopia.

METHODS Myopic children (spherical equivalent refraction, −0.75 to −4.00 D; astigmatism, <1.00 D) aged 8 to 12 years with no prior contact lens experience were enrolled in a 3-year, double-masked, randomized clinical trial at four investigational sites in four countries. Subjects in each group were matched for age, sex, and ethnicity and were randomized to either a MiSight 1-day contact lens (test) or Proclear 1-day (control; omafilcon A) and worn on a daily disposable basis. Primary outcome measures were the change in cycloplegic spherical equivalent refraction and axial length.

RESULTS Of the subjects enrolled, 75.5% (109/144) completed the clinical trial (53 test, 56 control). Unadjusted change in spherical equivalent refraction was −0.73 D (59%) less in the test group than in the control group (−0.51 ± 0.64 vs. –1.24 ± 0.61 D, P < .001). Mean change in axial length was 0.32 mm (52%) less in the test group than in the control group (0.30 ± 0.27 vs. 0.62 ± 0.30 mm, P < .001). Changes in spherical equivalent refraction and axial length were highly correlated (r = −0.90, P < .001). Over the course of the study, there were no cases of serious ocular adverse events reported. Four asymptomatic corneal infiltrative (one test, three control) events were observed at scheduled study visits.

CONCLUSIONS Results of this clinical trial demonstrate the effectiveness of the MiSight daily disposable soft contact lens in slowing change in spherical equivalent refraction and axial length.

A 3-Year Randomized Clinical Trial of MiSight Lenses for Myopia Control is published on the Optometry and Vision Science: July 19, 2019. 

For more information on myopia management, please call 6777 6058 or send us an enquiry.